Background: The worldwide misuse of antibiotics is one of the main factors in microbial resistance that is a serious threat worldwide. Alternative strategies are needed to overcome this issue. Objectives: In this study, a novel strategy was adopted to suppress the growth of resistant pathogens through immobilization of silver nanoparticles (AgNPs) in gum of Moringa oleifera. Methods: The AgNPs were prepared from the leaves of Moringa oleifera and subsequently characterized through UV-spectrophotometry, FTIR, SEM, and XRD. The differential ratios of characterized AgNPs were immobilized with gum of M. oleifera and investigated for antimicrobial potential against highly resistant pathogens. Results: The immobilized AgNPs displayed promising activities against highly resistant B. subtilis (23.6 mm; 50 µL:200 µL), E. coli (19.3 mm; 75 µL:200 µL), K. pneumoniae (22 mm; 200 µL:200 µL), P. mirabilis (16.3 mm; 100 µL:200 µL), P. aeruginosa (22 mm; 175 µL:200 µL), and S. typhi (19.3; 25 µL:200 µL) than either AgNPs alone or gum. The immobilized AgNPs released positive sliver ions that easily attached to negatively charged bacterial cells. After attachment and permeation to bacterial cells, the immobilized NPs alter the cell membrane permeability, protein/enzymes denaturation, oxidative stress (ROS), damage DNA, and change the gene expression level. It has been mechanistically considered that the immobilized AgNPs can kill bacteria by damaging their cell membranes, dephosphorylating tyrosine residues during their signal transduction pathways, inducing cell apoptosis, rupturing organelles, and inhibiting cell division, which finally leads to cell death. Conclusions: This study proposes a potential alternative drug for curing various infections.
The misuse of antibiotics generates resistant bacterial strains that are extremely dangerous and pose a serious threat to global health systems. This global issue needs a rapid and urgent alternative to control the growth of resistant strains. In this study, a novel strategy was adopted to suppress the growth of resistant pathogens. Here, an immobilization approach was applied using silver nanoparticles (AgNPs) and gum of medicinally important Moringa oleifera. In many studies, the gum and AgNPs alone have proven antibacterial activities. Here, the differential concentrations of AgNPs were immobilized with gum of M. oleifera to investigate its potential against highly resistant pathogens. Immobilization is a powerful technique that is commonly used in pharmaceutics for controlled reactivity and emulsification. The immobilized AgNPs displayed promising activities against highly resistant B. subtilis (23.6mm, 50 µL:200 µL), E. coli (19.3; 75 µL:200 µL), K. pneumoniae (22 mm; 200 µL:200 µL), P. mirabilis (16.3 mm; 100 µL:200 µL), P. aeruginosa (22 mm; 175 µL:200 µL) and S. typhi (19.3; 25 µL: 200 µL) than either AgNPs alone or gum. The immobilized AgNPs released the positive sliver ions and the positively charged nanoparticles (NPs) are attracted by the negatively charged bacterial cells. After attachment and permeation to bacterial cell, the immobilized NPs altering the cell membrane permeability, protein denaturation, causing oxidative stress, deactivating enzymes, generating ROS, DNA damage and changing gene expression level. It has been mechanistically considered that the immobilized AgNPs can kill bacteria by damaging their cell membranes, dephosphorylate tyrosine residues during their signal transduction pathways, cell apoptosis, rupture the organelles and inhibiting the cell division and finally lead to cell death. This study has a potential to be adopted by pharmaceutical industries as highly effective antibacterial alternatives to synthetic drugs.
1
4 December 2024 in Frontiers in Health Informatics
Background: Hepatitis E is a significant public health concern, especially in developing countries, due to its association with waterborne outbreaks. It accounts for a large proportion of enteric-transmitted liver diseases worldwide. In developed nations, cases of hepatitis E are rare and typically linked to travellers from endemic regions or individuals without identifiable risk factors. Objective: To provide an overview of the hepatitis E virus (HEV), including its virology, transmission, zoonotic potential, and treatment options. Methods: A review of current literature on HEV epidemiology, virology, modes of transmission, and treatment approaches, with a focus on genotype distribution and its impact on public health. Results: HEV is a single-stranded, non-enveloped RNA virus with one serotype and four genotypes. Genotypes 1 and 2 are primarily found in developing countries and exclusively infect humans, while genotypes 3 and 4, common in industrialized countries, infect humans and other mammals, especially pigs. HEV is increasingly recognized as a zoonotic.